SCHEMBL101785

SCHEMBL101785

Nc1cc(F)ccc1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27546033 0.97 ALDH1A1 (0.50)
Bicarbonate SCHEMBL1006778 0.91 KEAP1 (0.53)
SCHEMBL21369192 0.81 ALDH1A1 (0.67)
SCHEMBL102227 0.79
SCHEMBL20495290 0.78 NPC1 (0.49)
SCHEMBL13652988 0.78 ALDH1A1 (0.59)
SCHEMBL11198490 0.78 MAPT (0.46)
Hydrochloric Acid SCHEMBL28135844 0.77 ALDH1A1 (0.54)
SCHEMBL11202666 0.77 GRM5 (0.42)
SCHEMBL29476041 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 562 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119735977-B PCB gold panel printing diffusion inhibitor and preparation and use methods thereof 深圳市板明科技股份有限公司 2025-05-02 CN claimed
CN-119735977-A PCB gold panel printing diffusion inhibitor and preparation and use methods thereof 深圳市板明科技股份有限公司 2025-04-01 CN claimed
US-20230295632-A1 METHODS OF CONTROLLING RED BLOOD CELL PRODUCTION WISCONSIN ALUMNI RESEARCH FOUNDATION 2023-09-21 US claimed
CN-115020112-B Configuration-controllable nitrogen-oxygen-fluorine co-doped carbon electrode material and preparation method thereof 燕山大学 2023-05-16 CN claimed
CN-115505581-A arylamine-N acetyltransferase mutant and application thereof 中国科学院青岛生物能源与过程研究所 2022-12-23 CN claimed
CN-115020112-A Configuration-controllable nitrogen oxygen fluorine co-doped carbon electrode material and preparation method thereof 燕山大学 2022-09-06 CN claimed
CN-111952549-B Carbon-coated lithium battery negative electrode material with yolk-eggshell structure and preparation method thereof 宝山钢铁股份有限公司 2021-08-17 CN claimed
CN-111952549-A Carbon-coated lithium battery negative electrode material with yolk-eggshell structure and preparation method thereof 宝山钢铁股份有限公司 2020-11-17 CN claimed
US-20190270992-A1 METHODS OF CONTROLLING RED BLOOD CELL PRODUCTION WISCONSIN ALUMNI RESEARCH FOUNDATION 2019-09-05 US claimed
CN-103048465-B IL-6 (Inter Leukin-6) micro-pore plate type chemiluminescent detection kit and manufacturing method thereof TARCINE BIOMED BEIJING INC 2015-07-22 CN claimed
US-20100297155-A1 PHOSPHAZENE HYDROGELS WITH CHEMICAL CORSS-LINK, PREPARATION METHOD THEREOF AND USE THEREOF DECA ITALIA S.R.L. (IT) 2010-11-25 US claimed
EP-2155806-A1 PHOSPHAZENE HYDROGELS WITH CHEMICAL CORSS -LINK, PREPARATION METHOD THEREOF AND USE THEREOF Korea Institute of Science and Technology (KR) 2010-02-24 EP claimed
WO-2008153278-A1 PHOSPHAZENE HYDROGELS WITH CHEMICAL CORSS -LINK, PREPARATION METHOD THEREOF AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2008-12-18 WO claimed
US-7041787-B2 Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases KIMBERLY-CLARK WORLDWIDE, INC. (US) 2006-05-09 US claimed
EP-1157029-B1 OLIGOPEPTIDE DERIVATIVES FOR THE ELECTROCHEMICAL MEASUREMENT OF PROTEASE ACTIVITY PENTAPHARM AG (CH) 2005-12-28 EP claimed
US-6495336-B1 OLIGOPEPTIDE DERIVATIVES WHOSE C-TERMINAL AMINO ACID IS ARGININE WHICH IS LINKED TO THE REMAINDER OF AN ELECTROACTIVE ANILINE OR AMINOQUINILONE; SUBSTRATE FOR QUANTITATIVELY DETERMINING ENZYMES, ESPECIALLY THROMBIN, IN BLOOD PENTAPHARM AG (CH) 2002-12-17 US claimed
EP-1157029-A1 OLIGOPEPTIDE DERIVATIVES FOR THE ELECTROCHEMICAL MEASUREMENT OF PROTEASE ACTIVITY Pentapharm AG (CH) 2001-11-28 EP claimed
WO-2000050446-A1 OLIGOPEPTIDE DERIVATIVES FOR THE ELECTROCHEMICAL MEASUREMENT OF PROTEASE ACTIVITY PENTAPHARM AG (CH) 2000-08-31 WO claimed
EP-0973767-A1 INDAZOLES OF CYCLIC UREAS USEFUL AS HIV PROTEASE INHIBITORS Dupont Pharmaceuticals Company (US) 2000-01-26 EP claimed
WO-1998043969-A1 INDAZOLES OF CYCLIC UREAS USEFUL AS HIV PROTEASE INHIBITORS DUPONT PHARMACEUTICALS COMPANY (US) 1998-10-08 WO claimed